Serum ghrelin levels in patients with Behcet's disease

3Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Introduction: Behcet's disease (BD) is a chronic, relapsing, systemic vasculitis of unknown etiology. Aim: To measure serum ghrelin levels in BD patients and healthy controls and to investigate its association with metabolic syndrome (MetS). Material and methods: Thirty BD patients and 30 healthy individuals were enrolled in the study. Ghrelin levels were measured in blood samples using ELISA. Results: The mean serum ghrelin level in BD patients (28.57 ±14.04) was significantly lower compared to healthy controls (40.72 ±23.21) (p = 0.01). The mean serum ghrelin level in BD patients who had MetS (24.18 ±12.73) was lower compared to BD patients who did not have MetS (30.77 ±14.45), but this difference was not significant (p > 0.05). Conclusions: Ghrelin levels were lower in BD patients compared to healthy controls. There was no association between reduced ghrelin levels and MetS; however, there was a negative correlation between ghrelin levels and disease activity.

Cite

CITATION STYLE

APA

Erden, I., Uçak, H., Demir, B., Cicek, D., Dertlioglu, S. B., Aydin, S., & Ozturk, S. (2016). Serum ghrelin levels in patients with Behcet’s disease. Postepy Dermatologii i Alergologii, 33(6), 450–456. https://doi.org/10.5114/ada.2016.63884

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free